Compare EHang Holdings Ltd - ADR (EH) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
EHang Holdings Ltd - ADR vs Health Care Select Sector SPDR Fund — how do they compare? EHang Holdings Ltd - ADR trades at $4.19 (market cap $309.45M), while Health Care Select Sector SPDR Fund trades at $170.81 (market cap $43.48B). The key difference: Health Care Select Sector SPDR Fund is far larger — about 140.5× EHang Holdings Ltd - ADR's market cap, and Health Care Select Sector SPDR Fund is trading nearer its 52-week high, EHang Holdings Ltd - ADR nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold EHang Holdings Ltd - ADR for 47 Days and Health Care Select Sector SPDR Fund for 100 Days on average.
| EH | XLV | |
|---|---|---|
Market Cap | $309.45M | $43.48B |
Volume | 765,799 | 11,121,431 |
Sector | Industrials | — |
52-Week High | $18.94 | $175.68 |
52-Week Low | $4.03 | $141.95 |
Typical Hold Time | 47 Days | 100 Days |
Enterprise Value | $261.14M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EHang Holdings (EH) trades at $4.08, down 1.45% on the day, with a bearish technical signal driven by moving averages. The company reported revenue of $418 million in 2025 but posted a net loss of $276 million, with negative profitability margins and a P/S ratio of 5.38. Recent news highlights regulatory investigations and expansion of its eVTOL program in Vietnam, creating mixed sentiment amid operational progress and legal scrutiny.
The outlook remains challenged by persistent losses and high cash burn, though expansion initiatives offer long-term potential. Key risks include regulatory hurdles, competitive pressures, and reliance on financing. Analyst consensus is divided, with 20% buy ratings, reflecting cautious optimism balanced against fundamental weaknesses.
XLV trades at $168.16, down 0.39% with a bearish technical signal from moving averages. The healthcare ETF maintains strong cost advantages with a 0.08% expense ratio compared to peers. Recent news highlights XLV's defensive positioning during market volatility and its historical outperformance during Fed rate hikes. Technical indicators show RSI levels in neutral territory while ADX signals selling pressure.
XLV offers diversified healthcare exposure with competitive expense ratios, positioning it well for defensive investing. Key risks include political uncertainty around healthcare policy and concentrated exposure to domestic S&P 500 stocks. The ETF's low-cost structure and sector diversification provide stability amid market volatility, though technical indicators suggest near-term caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About EHang Holdings Ltd - ADR
EHang Holdings Ltd is an autonomous aerial vehicle (AAV) technology platform company. It focuses on making safe, autonomous and eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with AAV products and commercial solutions: air mobility (including passenger transportation and logistics), smart city management and aerial media solutions. As the forerunner of cutting-edge AAV technologies and commercial solutions in the global Urban Air Mobility industry, it continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.
Read more on EH →About Health Care Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →
